A Short Peptide That Mimics the Binding Domain of TGF-β1 Presents Potent Anti-Inflammatory Activity
Fig 4
Cytotoxicity analysis of the synthetic peptide in PBMC.
The pm26TGF-β1 peptide showed no statistical difference when compared to control (PBMC without treatment) indicating that the tested concentrations did not have a cytotoxic effect.